RAFAEL HOLDINGS, INC. Cash and Cash Equivalents
RAFAEL HOLDINGS, INC. (RFL) had Cash and Cash Equivalents of $30.50 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-06-11
- 2026-04-30: Cash and Cash Equivalents, at Carrying Value $30.50M.
- 2026-01-31: Cash and Cash Equivalents, at Carrying Value $37.78M.
- 2025-10-31: Cash and Cash Equivalents, at Carrying Value $45.54M.
- 2025-07-31: Cash and Cash Equivalents, at Carrying Value $52.77M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-04-30 | $30.50M 10-Q · filed 2026-06-11 | |
| 2026-01-31 | $37.78M 10-Q · filed 2026-03-16 | |
| 2025-10-31 | $45.54M 10-Q · filed 2025-12-12 | |
| 2025-07-31 | $52.77M 10-Q · filed 2026-06-11 | |
| 2025-04-30 | $37.94M 10-Q · filed 2025-06-11 | |
| 2025-01-31 | $48.32M 10-Q · filed 2025-03-14 | |
| 2024-10-31 | $8.16M 10-Q · filed 2024-12-11 | |
| 2024-07-31 | $2.67M 10-K · filed 2025-10-29 | |
| 2024-04-30 | $7.44M 10-Q · filed 2024-06-14 | |
| 2024-01-31 | $7.14M 10-Q · filed 2024-03-14 | |
| 2023-10-31 | $13.20M 10-Q · filed 2023-12-14 | |
| 2023-07-31 | $21.50M 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $15.44M 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $9.67M 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $22.17M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $26.54M 10-K · filed 2023-10-30 | |
| 2021-10-31 | $72.39M 10-Q · filed 2022-12-13 | $77.39M 10-Q · filed 2021-12-15 |
| 2021-07-31 | $7.85M 10-K · filed 2022-10-31 | $12.85M 10-K · filed 2021-10-18 |
| 2021-04-30 | $4.68M 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $6.09M 10-Q · filed 2021-03-17 | |
| 2020-10-31 | $7.23M 10-Q/A · filed 2022-02-28 | |
| 2020-07-31 | $6.21M 10-Q/A · filed 2022-02-28 | |
| 2020-04-30 | $8.43M 10-Q · filed 2021-06-14 | |
| 2020-01-31 | $9.52M 10-Q · filed 2021-03-17 | |
| 2019-10-31 | $10.77M 10-Q · filed 2020-12-15 | |
| 2019-07-31 | $12.02M 10-K · filed 2021-10-18 | |
| 2019-04-30 | $12.97M 10-Q · filed 2020-06-09 | |
| 2019-01-31 | $14.77M 10-Q · filed 2020-03-05 | |
| 2018-10-31 | $10.09M 10-Q · filed 2019-12-09 | |
| 2018-07-31 | $15.80M 10-K · filed 2020-10-29 | |
| 2018-04-30 | $10.61M 10-Q · filed 2019-06-05 | |
| 2018-01-31 | $12.01M 10-Q · filed 2019-03-12 | |
| 2017-10-31 | $11.52M 10-Q · filed 2018-12-10 | |
| 2017-07-31 | $11.76M 10-K · filed 2019-10-04 | |
| 2017-04-30 | $11.73M 10-Q · filed 2018-06-11 | |
| 2017-01-31 | $11.86M 10-Q · filed 2018-03-12 | |
| 2016-07-31 | $2.34M 10-K · filed 2018-10-15 | |
| 2015-07-31 | $5.65M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |